Scinai Immunotherapeutics (FRA:2F5) Accumulated other comprehensive income (loss) : €-1.66 Mil (As of Dec. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Scinai Immunotherapeutics Accumulated other comprehensive income (loss)?

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings. Scinai Immunotherapeutics's Accumulated other comprehensive income (loss) for the quarter that ended in Dec. 2024 was €-1.66 Mil.

Scinai Immunotherapeutics's quarterly Accumulated other comprehensive income (loss) increased from Jun. 2024 (€-1.62 Mil) to Sep. 2024 (€-1.57 Mil) but then declined from Sep. 2024 (€-1.57 Mil) to Dec. 2024 (€-1.66 Mil).

Scinai Immunotherapeutics's annual Accumulated other comprehensive income (loss) increased from Dec. 2022 (€-1.90 Mil) to Dec. 2023 (€-1.60 Mil) but then declined from Dec. 2023 (€-1.60 Mil) to Dec. 2024 (€-1.66 Mil).

Scinai Immunotherapeutics Accumulated other comprehensive income (loss) Historical Data

The historical data trend for Scinai Immunotherapeutics's Accumulated other comprehensive income (loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Scinai Immunotherapeutics Accumulated other comprehensive income (loss) Chart

Scinai Immunotherapeutics Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Accumulated other comprehensive income (loss)

Get a 7-Day Free Trial

-1.82

-1.90

-1.60

-1.66

Scinai Immunotherapeutics Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Accumulated other comprehensive income (loss)	Get a 7-Day Free Trial															-1.60	-1.60	-1.62	-1.57	-1.66

Scinai Immunotherapeutics Accumulated other comprehensive income (loss) Calculation

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings.

Scinai Immunotherapeutics Accumulated other comprehensive income (loss) Related Terms

Thank you for viewing the detailed overview of Scinai Immunotherapeutics's Accumulated other comprehensive income (loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

Scinai Immunotherapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Scinai Immunotherapeutics Ltd (FRA:2F5) » Definitions » Accumulated other comprehensive income (loss)

Comparable Companies

Traded in Other Exchanges

SCNI:USA

Address

Hadassah Ein Kerem Campus, 2nd Floor, Jerusalem BioPark, Jerusalem, ISR

Website

https://www.scinai.com

Scinai Immunotherapeutics Ltd is a biopharmaceutical company with two complementary business units, one focused on in-house development of inflammation and immunology (I&I) biological therapeutic products beginning with a pipeline of nanosized VHH antibodies (NanoAbs) targeting diseases with large unmet medical needs, and the other a boutique CDMO providing services to help biotech companies efficiently bring their products to market by leveraging Scinai's drug development and GMP and non-GMP manufacturing capabilities for pre-clinical and clinical studies. The company generates maximum revenue from the provision of CDMO (Contract Development and Manufacturing Organization) services.

Scinai Immunotherapeutics Headlines

No Headlines